Amplao, Anelyn .
HRN: 26-64-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/08/2025
METRONIDAZOLE 500MG (TAB)
02/08/2025
02/14/2025
PO
1 Tab
TID
S/p NSVD; Thickly MSAF
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes